跳至主要内容
临床试验/NCT02902393
NCT02902393Unknown不适用

Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
64
试验地点
1
主要终点
Evaluation of revascularisation 24 hours after tPA injection using CT scan or MRI

研究概览

简要总结

Revascularisation using recombinant tPA is the reference treatment of stroke. However, the efficacy of fibrinolysis is about 50%. Several factors, including the size of thrombus, have been associated with revascularisation efficacy.

The aim of this prospective study is to evaluate ex vivo the effect of tPA in patients with stroke with thromboelastography and to correlate results with the clinical outcome of patients. Results may predict revascularisation in patients with stroke.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient (> 18 years) with a neurological deficit compatible with a neurovascular pathology eligible for fibrinolysis rtPA and having a proximal occlusion of the middle cerebral artery (segment M1 / M2) or basilar trunk objectified brain imaging (MRI angiography or angio CT).

排除标准

  • Any patient with major comorbidity, a pathology of hemostasis or anticoagulant treatment (vitamin K antagonist (VKA), direct oral anticoagulant).

结局指标

主要结局

Evaluation of revascularisation 24 hours after tPA injection using CT scan or MRI

时间窗: 24 hours

次要结局

  • Clinical evaluation using NIHSS scale(24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验